A detailed history of Advisors Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Advisors Capital Management, LLC holds 695,177 shares of BMY stock, worth $40.2 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
695,177
Previous 174,679 297.97%
Holding current value
$40.2 Million
Previous $7.25 Million 395.85%
% of portfolio
0.59%
Previous 0.13%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$39.66 - $51.75 $20.6 Million - $26.9 Million
520,498 Added 297.97%
695,177 $36 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $451,202 - $594,017
11,210 Added 6.86%
174,679 $7.25 Million
Q1 2024

May 06, 2024

BUY
$47.98 - $54.4 $1.24 Million - $1.4 Million
25,768 Added 18.71%
163,469 $8.87 Million
Q4 2023

Feb 14, 2024

SELL
$48.48 - $57.85 $176,903 - $211,094
-3,649 Reduced 2.58%
137,701 $7.07 Million
Q3 2023

Nov 15, 2023

BUY
$57.89 - $64.73 $348,729 - $389,933
6,024 Added 4.45%
141,350 $8.2 Million
Q2 2023

Aug 03, 2023

SELL
$63.71 - $70.74 $3.88 Million - $4.31 Million
-60,968 Reduced 31.06%
135,326 $8.65 Million
Q1 2023

May 04, 2023

BUY
$65.71 - $74.53 $739,434 - $838,686
11,253 Added 6.08%
196,294 $13.6 Million
Q4 2022

Feb 13, 2023

BUY
$68.48 - $81.09 $158,873 - $188,128
2,320 Added 1.27%
185,041 $13.3 Million
Q3 2022

Nov 16, 2022

BUY
$0.13 - $76.84 $2,122 - $1.25 Million
16,327 Added 9.81%
182,721 $14 Million
Q2 2022

Aug 12, 2022

BUY
$72.62 - $79.98 $314,299 - $346,153
4,328 Added 2.67%
166,394 $12.8 Million
Q1 2022

May 10, 2022

SELL
$61.48 - $73.72 $235,837 - $282,789
-3,836 Reduced 2.31%
162,066 $11.8 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $358,516 - $417,946
6,685 Added 4.2%
165,902 $10.3 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $93,370 - $109,371
1,578 Added 1.0%
159,217 $9.42 Million
Q2 2021

Aug 02, 2021

SELL
$61.91 - $67.42 $12.5 Million - $13.6 Million
-201,995 Reduced 56.17%
157,639 $10.5 Million
Q1 2021

May 12, 2021

BUY
$59.34 - $66.74 $444,990 - $500,483
7,499 Added 2.13%
359,634 $22.7 Million
Q4 2020

Feb 16, 2021

SELL
$57.74 - $65.43 $3.03 Million - $3.43 Million
-52,483 Reduced 12.97%
352,135 $21.8 Million
Q3 2020

Nov 05, 2020

SELL
$57.43 - $63.64 $1.67 Million - $1.86 Million
-29,165 Reduced 6.72%
404,618 $24.4 Million
Q2 2020

Aug 18, 2020

SELL
$54.82 - $64.09 $4.13 Million - $4.83 Million
-75,333 Reduced 14.8%
433,783 $25.5 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $521,768 - $758,250
11,245 Added 2.26%
509,116 $28.4 Million
Q4 2019

Jan 10, 2020

BUY
$49.21 - $64.19 $1.12 Million - $1.47 Million
22,836 Added 4.81%
497,871 $32 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $1.85 Million - $2.19 Million
43,180 Added 10.0%
475,035 $24.1 Million
Q2 2019

Aug 15, 2019

BUY
$44.62 - $49.34 $1.3 Million - $1.44 Million
29,181 Added 7.25%
431,855 $19.6 Million
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $7.29 Million - $8.69 Million
161,585 Added 67.02%
402,674 $19 Million
Q4 2018

Jan 17, 2019

SELL
$48.76 - $63.23 $256,136 - $332,147
-5,253 Reduced 2.13%
241,089 $12.5 Million
Q3 2018

Oct 10, 2018

SELL
$55.19 - $62.25 $563,876 - $636,008
-10,217 Reduced 3.98%
246,342 $15.3 Million
Q2 2018

Aug 13, 2018

BUY
$50.53 - $62.98 $13 Million - $16.2 Million
256,559 New
256,559 $14.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Advisors Capital Management, LLC Portfolio

Follow Advisors Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisors Capital Management, LLC with notifications on news.